ADMA Biologics is a startup. 1 investor tracked.
ADMA Biologics is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
ADMA Biologics is an end-to-end commercial biopharmaceutical company that manufactures, markets, and develops specialty plasma-derived products for the prevention and treatment of infectious diseases in immunocompromised and other patients at risk for infection.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.